Intriguingly, diminished L-arg concentrations have been shown to induce accumulation of arginase-expressing MDSCs in the tumors after administration of pegylated recombinant ARG1 to tumor-bearing mice (158) indicating potential threats associated with L-arg-depleting therapeutic strategies for cancer. This evidence concerns the gene ARHGEF12 and neoplasm.